In statistical research, it’s important to have a good data set. The idea is that the more information available to analyze, the better the analysis will be. For the researchers at Boston University who investigated the connection between selective serotonin reuptake inhibitors (SSRIs) such as Zoloft (sertraline) and certain birth defects, the data set couldn’t be much more conclusive.
In a study of more than 15,000 infants, these researchers found that a pregnant mother’s use of sertraline during the first trimester of pregnancy measurably increased the probability of several kinds of birth defects, including anal atresia, limb reduction, and septal defects. While the absolute risk may be small, the increase is noticeable.
What do these findings mean for you and your family? If you took Zoloft during the first trimester of your pregnancy, there may be a connection between your child’s exposure to this dangerous drug and his or her birth defects. To find out more about this research and to learn about the legal implications, talk to the professionals at Fears Nachawati. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com.